Abstract:Purpose of review: The goals of this review are two folds: (1) to describe the recent understandings on the roles of calcitonin gene-related peptide-α (CGRP) in bone homeostasis and the underlying mechanisms of related neuronal regulation and (2) to propose innovative CGRP-modulated approaches for enhancing bone regeneration in challenging bone disorders. Recent findings: CGRP is predominantly produced by the densely distributed sensory neuronal fibers in bone, declining with age. Under mechanical and biochemical stimulations, CGRP releases and exerts either physiological or pathophysiological roles. CGRP at physiological level orchestrates the communications of bone cells with cells of other lineages, affecting not only osteogenesis, osteoclastogenesis, and adipogenesis but also angiogenesis, demonstrating with pronounced anabolic effect, thus is essential for maintaining bone homeostasis, with tuned nerve-vessel-bone network. In addition, its effects on immunity and cell recruitment are also crucial for bone fracture healing. Binding to the G protein-coupled receptor composited by calcitonin receptor-like receptor (CRLR) and receptor activity modifying protein 1 (RAMP1) on cellular surface, CGRP triggers various intracellular signaling cascades involving cyclic adenosine monophosphate (cAMP) and cAMP response element-binding protein (CREB). Peaking at early stage post-fracture, CGRP promotes bone formation, displaying with larger callus. Then CGRP gradually decreases over time, allowing normal or physiological bone remodeling. By elevating CGRP at early stage, low-intensity pulsed ultrasound (LIPUS), electrical stimulation, and magnesium-based bio-mineral products may promisingly accelerate bone regeneration experimentally in medical conditions like osteoporosis, osteoporotic fracture, and spine fusion. Excess CGRP expression is commonly observed in pathological conditions including cancer metastatic lesions in bone and fracture delayed- or non-healing, resulting in persistent chronic pain. To date, these discoveries have largely been limited to animal models. Clinical applications are highly desirable. Compelling evidence show the anabolic effects of CGRP on bone in animals. However, further validation on the role of CGRP and the underlying mechanisms in human skeletons is required. It remains unclear if it is type H vessel connecting neuronal CGRP to osteogenesis, and if there is only specific rather than all osteoprogenitors responsible to CGRP. Clear priority should be put to eliminate these knowledge gaps by integrating with high-resolution 3D imaging of transparent bulk bone and single-cell RNA-sequencing. Last but not the least, given that small molecule antagonists such as BIBN4096BS can block the beneficial effects of CGRP on bone, concerns on the potential side effects of humanized CGRP-neutralizing antibodies when systemically administrated to treat migraine in clinics are arising.

Neural Peptide Promotes the Angiogenesis and Osteogenesis Around Oral Implants.

Neural Peptide α-CGRP Coregulated Angiogenesis and Osteogenesis via Promoting the Cross-Talk between Mesenchymal Stem Cells and Endothelial Cells

CGRP-alpha Application: a Potential Treatment to Improve Osseoperception of Endosseous Dental Implants.

Yes-associated protein promotes bone healing after tooth extraction in mice

Inhibition of Osteogenesis Surrounding the Titanium Implant by CGRP Deficiency

Effect of lentiviral vector overexpression α-calcitonin gene-related peptide on titanium implant osseointegration in α-CGRP-deficient mice

αCGRP Regulates Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells Through ERK1/2 and p38 MAPK Signaling Pathways

The Effects of Calcitonin Gene-Related Peptide on Bone Homeostasis and Regeneration

Effect of CGRP-Adenoviral Vector Transduction on the Osteoblastic Differentiation of Rat Adipose-Derived Stem Cells

Vascular Endothelial Growth Factor Pathway Promotes Osseointegration and CD31(hi)EMCN(hi) Endothelium Expansion in a Mouse Tibial Implant Model AN ANIMAL STUDY

PLGA Containing Human Adipose-Derived Stem Cell-Derived Extracellular Vesicles Accelerates the Repair of Alveolar Bone Defects via Transfer of CGRP

A Novel Porous Hydroxyapatite Scaffold (phamg) Enhances Angiogenesis and Osteogenesis Around Dental Implants by Regulating the Immune Microenvironment.

Sensory neuron transient receptor potential vanilloid-1 channel regulates angiogenesis through CGRP in vivo

The Osteogenesis Effect and Underlying Mechanisms of Local Delivery of Gapn in Extraction Sockets of Beagle Dogs.

Neuronal TRPV1-CGRP axis regulates bone defect repair through Hippo signaling pathway

Vascular endothelial growth factor pathway promotes osseointegration and CD31<sup>hi</sup>EMCN<sup>hi</sup> endothelium expansion in a mouse tibial implant model

Vascular endothelial growth factor pathway promotes osseointegration and CD31hiEMCNhi endothelium expansion in a mouse tibial implant model: an animal study

Calcitonin gene-related peptide enhances osteogenic differentiation and recruitment of bone marrow mesenchymal stem cells in rats.

Application of the neuropeptide NPVF to enhance angiogenesis and osteogenesis in bone regeneration

Early effects of parathyroid hormone on vascularized bone regeneration and implant osseointegration in aged rats.

Effects of Vascular Endothelial Growth Factor on Osteoblasts Around Dental Implants in Vitro and in Vivo